Walleye Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Walleye Capital's ELV Position: Q1 2026 in Review
Walleye Capital reduced its Elevance Health (ELV) stake by 97% in Q1 2026, selling an estimated $34.9M and leaving 3,024 shares worth $885K. The position accounts for ﹤0.01% of the portfolio, ranked #2192.
Walleye Capital first reported a position in ELV in Q3 2018 and has held it in 17 quarters since. The position peaked at $38.3M in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Walleye Capital held 3,024 shares of Elevance Health worth $885K as of Q1 2026.
- Walleye Capital sold 106,159 Elevance Health shares in Q1 2026, an estimated $34.9M.
- Elevance Health made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2192 holding.
- Walleye Capital first reported a position in Elevance Health in Q3 2018 and has held it in 17 quarters since.
- Walleye Capital's Elevance Health position peaked at $38.3M in Q4 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.